Atlas FDA

OrganOx metra System

FDA premarket approval P200035 · decided 2021-12-09

Approval details

PMA number
P200035
Trade name
OrganOx metra System
Generic name
Normothermic machine perfusion system for the preservation of donor livers prior to transplantation
Applicant
Organox Limited
Date received
2020-07-15
Decision date
2021-12-09
Days to decision
512 days
Decision code
APPR
Product code
QQK
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
Oxford
Statement
Approval for the OrganOx metra System. The device is approved for the following indication: The OrganOx metra® is a transportable device intended to be used to sustain donor livers destined for transplantation in a functioning state for a total preservation time of up to 12 hours.The OrganOx metra® device is suitable for liver grafts from donors after brain death (DBD), or liver grafts from donors after circulatory death (DCD) <=40 years old, with <=20 mins of functional warm ischemic time (time

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.